Evidence map›Paper›PMID 28430817›Full record

ArticlePLoS pathogens2017

Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.

Giuseppe Mariggiò, Sandra Koch, Guigen Zhang, Magdalena Weidner-Glunde, Jessica Rückert, Semra Kati, Susann Santag, Thomas F Schulz

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. SMC-based immunity against extrachromosomal DNA elements.Biochemical Society transactions · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Interplay Between KSHV and the Host DNA Damage Response.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Giuseppe MariggiòInstitute of Virology, Hannover Medical School, Hannover, Germany.
Sandra KochInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-3759-9996
Guigen ZhangInstitute of Virology, Hannover Medical School, Hannover, Germany.
Magdalena Weidner-GlundeInstitute of Virology, Hannover Medical School, Hannover, Germany.
Jessica RückertInstitute of Virology, Hannover Medical School, Hannover, Germany.
Semra KatiInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0003-4606-8441
Susann SantagInstitute of Virology, Hannover Medical School, Hannover, Germany.
Thomas F SchulzInstitute of Virology, Hannover Medical School, Hannover, Germany.ORCID http://orcid.org/0000-0001-8792-5345
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaposi Sarcoma Herpesvirus (KSHV), a γ2-herpesvirus and class 1 carcinogen, is responsible for at least three human malignancies: Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL) and Multicentric Castleman's Disease (MCD). Its major nuclear latency protein, LANA, is indispensable for the maintenance and replication of latent viral DNA in infected cells. Although LANA is mainly a nuclear protein, cytoplasmic isoforms of LANA exist and can act as antagonists of the cytoplasmic DNA sensor, cGAS. Here, we show that cytosolic LANA also recruits members of the MRN (Mre11-Rad50-NBS1) repair complex in the cytosol and thereby inhibits their recently reported role in the sensing of cytoplasmic DNA and activation of the NF-κB pathway. Inhibition of NF-κB activation by cytoplasmic LANA is accompanied by increased lytic replication in KSHV-infected cells, suggesting that MRN-dependent NF-κB activation contributes to KSHV latency. Cytoplasmic LANA may therefore support the activation of KSHV lytic replication in part by counteracting the activation of NF-κB in response to cytoplasmic DNA. This would complement the recently described role of cytoplasmic LANA in blocking an interferon response triggered by cGAS and thereby promoting lytic reactivation. Our findings highlight a second point at which cytoplasmic LANA interferes with the innate immune response, as well as the importance of the recently discovered role of cytoplasmic MRN complex members as innate sensors of cytoplasmic DNA for the control of KSHV replication.

Indexed as

DNA ReplicationSignal TransductionVirus ReplicationAcid Anhydride HydrolasesAntigens, ViralCell Cycle ProteinsCytoplasmDNA-Binding ProteinsDNA Repair EnzymesDNA, ViralHEK293 CellsHerpesvirus 8, HumanHumansImmunity, InnateModels, BiologicalMRE11 Homologue ProteinAcid Anhydride HydrolasesAntigens, ViralCell Cycle ProteinsDNA-Binding ProteinsDNA Repair EnzymesDNA, Virallatency-associated nuclear antigenMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNF-kappa BNuclear ProteinsProtein IsoformsRAD50 protein, human

Identifiers

PMID28430817
PMCPMC5415203
OpenAlexW2605824527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.